Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

[1]  F. Sato,et al.  RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas , 2006, International journal of cancer.

[2]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[3]  C. Croce,et al.  MicroRNA deregulation in human thyroid papillary carcinomas. , 2006, Endocrine-related cancer.

[4]  H. Soreq,et al.  MicroRNA modulation of megakaryoblast fate involves cholinergic signaling. , 2006, Leukemia research.

[5]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[6]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[7]  Tim Clausen,et al.  The Role of Human HtrA1 in Arthritic Disease* , 2006, Journal of Biological Chemistry.

[8]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[9]  George A. Calin,et al.  Mammalian microRNAs: a small world for fine-tuning gene expression , 2006, Mammalian Genome.

[10]  J. Mendell,et al.  MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.

[11]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[13]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Crowe,et al.  Regulation of ERK1 gene expression by coactivator proteins. , 2005, The Biochemical journal.

[15]  O. Sheils.  Molecular classification and biomarker discovery in papillary thyroid carcinoma , 2005, Expert review of molecular diagnostics.

[16]  Manuela Gariboldi,et al.  Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[18]  G. Maira,et al.  Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.

[19]  R. Hruban,et al.  Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma. , 2005, Biochimica et biophysica acta.

[20]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[21]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[22]  Gautam Chaudhuri,et al.  Alternative initiation and splicing in dicer gene expression in human breast cells , 2005, Breast Cancer Research.

[23]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[24]  Jacques Young,et al.  Expression, hormonal regulation, and subcellular localization of CCAAT/enhancer-binding protein-beta in rat and human thyrocytes. , 2005, Thyroid : official journal of the American Thyroid Association.

[25]  Krzysztof Fujarewicz,et al.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.

[26]  O. Sheils,et al.  ret/PTC and BRAF Act as Distinct Molecular, Time-Dependant Triggers in a Sporadic Irish Cohort of Papillary Thyroid Carcinoma , 2005, International journal of surgical pathology.

[27]  C. Croce,et al.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Croce,et al.  An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[30]  G. Tsujimoto,et al.  Gene Expression Profiling Identifies Platelet-Derived Growth Factor as a Diagnostic Molecular Marker for Papillary Thyroid Carcinoma , 2004, Clinical Cancer Research.

[31]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[33]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[34]  M. Willingham,et al.  Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors , 2003, Oncogene.

[35]  O. Andersson,et al.  Characterization and expression of the gene encoding membralin, an evolutionary conserved protein expressed in the central nervous system. , 2002, Brain research. Gene expression patterns.

[36]  John D. Scott,et al.  Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics , 2002, The Journal of cell biology.

[37]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Ambros,et al.  The timing of lin-4 RNA accumulation controls the timing of postembryonic developmental events in Caenorhabditis elegans. , 1999, Developmental biology.

[39]  J A Bond,et al.  Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. , 1998, The American journal of pathology.

[40]  U. Schindler,et al.  Synergistic Activation of the Germline ε Promoter Mediated by Stat6 and C/EBPβ , 1998, The Journal of Immunology.

[41]  G. Chiappetta,et al.  RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  T. L. Furminger,et al.  Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. , 1995, Human Molecular Genetics.

[43]  M. Santoro,et al.  Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. , 1994, Oncogene.

[44]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[45]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[46]  J. Ritz,et al.  Activation of a novel human transforming gene, ret, by DNA rearrangement , 1985, Cell.

[47]  F. Monzon.  MicroRNA Profiling Reveals Distinct Signatures in B Cell Chronic Lymphocytic Leukemias , 2006 .

[48]  K. Franssila,et al.  Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  M. Specht,et al.  Cyclooxygenase-2 expression in thyroid nodules. , 2002, The Journal of clinical endocrinology and metabolism.

[50]  U. Schindler,et al.  Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta. , 1998, Journal of immunology.

[51]  T. Fahey,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(7):3214–3223 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-031811 Molecular Profiling Distinguishes Papillary Carcinoma , 2022 .